A Phase 1, Open-label Study to Evaluate the Pharmacokinetics of Tralokinumab in Adolescents With Asthma

Trial Profile

A Phase 1, Open-label Study to Evaluate the Pharmacokinetics of Tralokinumab in Adolescents With Asthma

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Mar 2017

At a glance

  • Drugs Tralokinumab (Primary)
  • Indications Asthma
  • Focus Pharmacokinetics
  • Sponsors MedImmune
  • Most Recent Events

    • 09 Jan 2013 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database.
    • 05 Dec 2012 Planned end date changed from 1 May 2013 to 1 Feb 2013 as reported by ClinicalTrials.gov.
    • 05 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top